The validity of this approach has been illustrated by two recent publications reporting derivation of iPSCs from AMD patients with ARMS2/HTRA1 high‐risk genotypes displaying reduced superoxide dismutase 2 (SOD2) defense, rendering RPE more susceptible to oxidative damage 24, 25. Here, ARMS2 is linked to age-related macular degeneration.